ADVERTISEMENT

Idera Pharmaceuticals Contact Us

512-226-8080

WebCorporate Headquarters 10801 N Mopac Expressway Building 1, Suite 100 Austin, TX, 78759 Phone 512-226-8080 E-Fax: 512.226.8441 info@idera.com Corporate PR/Media FOLIO Communications idera@foliocom.com press@idera.com Idera, Inc. Brand …

See Also: Phone Number PreviewShow details

ADVERTISEMENT

(512) 226-8080

WebAustin, Texas IDERA Headquarters 10801 N Mopac Expy Bldg 1-100 Austin, TX 78759-5460, USA Phone + 1 (512) 226-8080 E-Fax + 1 (512) 226-8441 Houston, Texas 5599 …

See Also: Phone Number PreviewShow details

WebDURHAM, N.C. and EXTON, Pa., Jan. 17, 2023 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera”) (Nasdaq: IDRA), a clinical-stage biopharmaceutical …

See Also: Phone Number PreviewShow details

WebAbout Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. …

Founder: Sudhir AgrawalLocation: Cambridge, MassachusettsFounded: Jul 1, 2007

See Also: Phone Number PreviewShow details

Idera, Inc. is the parent company of a portfolio of brands that offer B2B software including database tools, application development tools, test management tools, and DevOps tools. It is headquartered in Houston, Texas and has offices in Australia, Austria, and the United Kingdom. It is owned by the private equity firms HGGC, Partners Group and TA Associates.

Founder: Rick PleczkoFounded: 2000

See Also: Office PreviewShow details

ADVERTISEMENT

WebSep 28, 2022 · EXTON, PA and DURHAM, NC, September 28, 2022 — Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today announced it has completed the acquisition of …

See Also: Phone Number PreviewShow details

WebOur Vision. Aceragen is a rare disease biopharmaceutical company. We take on rare, orphan diseases that typically have no approved treatments, and to develop important …

See Also: Home Phone PreviewShow details

Web1 email found 2 phone numbers found Protected Content Senior Vice President, Product Leadership VP Management , Operations 1 email found 1 phone number found …

See Also: Phone Number PreviewShow details

WebCompany Information Email Format Management Idera Pharmaceuticals Information Idera Pharmaceuticals now Aceragen, a rare disease biopharmaceutical company. We …

See Also: Contact Support PreviewShow details

WebJan 17, 2023 · Investors & Media. Aceragen is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic …

See Also: Media PreviewShow details

WebNoveome Biotherapeutics, Inc. Pittsburgh, Pennsylvania Pieris Pharmaceuticals Boston, Massachusetts Alnylam Pharmaceuticals Cambridge, Massachusetts Krystal Biotech, Inc. Ex- Viropharma

See Also: Tech Support PreviewShow details

WebJan 17, 2023 · DURHAM, N.C. and EXTON, Pa., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (Nasdaq: IDRA), a clinical-stage …

See Also: Phone Number PreviewShow details

WebChief Executive Officer v*****@iderapharma.com +1******02 Louis Arcudi Senior Vice President Operations, Chief Financial Officer, Treasurer, and Secretary …

See Also: Contact Support PreviewShow details

ADVERTISEMENT

WebIdera: Q3 Earnings Snapshot AP - Mon Nov 8, 2021. EXTON, Pa. (AP) _ Idera Pharmaceuticals Inc. (IDRA) on Monday reported a loss of $6 million in its third quarter. …

See Also: Phone Number PreviewShow details

WebMar 18, 2021 · EXTON, Pa., March 18, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA; the “Company”) today is announcing that …

See Also: Phone Number PreviewShow details

(484) 348-1675

WebDec 15, 2020 · CONTACT: Idera Pharmaceuticals Contacts: Jill Conwell Investor Relations & Corporate Communications Phone (484) 348-1675 [email protected] John …

See Also: Phone Number PreviewShow details

WebMar 19, 2021 · Shares of Idera Pharmaceuticals ( IDRA -12.28%) were crashing 63.5% at 10:49 a.m. EDT on Friday. The plunge came after the company announced disappointing …

See Also: Phone Number PreviewShow details

Please leave your comments here:

 
ADVERTISEMENT
ADVERTISEMENT

ADVERTISEMENT

Popular Search